Tech Company Financing Transactions
Rejuvenation Technologies Funding Round
On 9/6/2023, Rejuvenation Technologies secured $10.6 million in Seed funding from Asymmetry Ventures, Khosla Ventures and Shanda Capital.
Transaction Overview
Company Name
Announced On
9/6/2023
Transaction Type
Venture Equity
Amount
$10,600,000
Round
Seed
Investors
Proceeds Purpose
The company intends to use the funds to advance its programs to IND approval in fibrotic disease, such as pulmonary fibrosis and liver cirrhosis, as well as early research targeting the immune system and bring on additional team members to oversee scale-up manufacturing, clinical operations, and R&D efforts to expand mRNA delivery capabilities to additional organ systems.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
415 Clyde Avenue Unit 107
Mountain View, CA 94043
USA
Mountain View, CA 94043
USA
Phone
Undisclosed
Website
Email Address
Overview
Rejuvenation Technologies is a longevity startup company based in Mountain View, California
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
John Ramunas
Chief Medical Officer
Dan Chambers
Chief Operating Officer
Glenn Markov
Browse more venture capital transactions:
Prev: 9/6/2023: SaaSGrid venture capital transaction
Next: 9/6/2023: Strise venture capital transaction
Share this article
News on VC Transactions
We report on all VC transactions involving tech companies. All VC database entries reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs